Dr. Nghiemphu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
10833 Le Conte Ave., CHS 36-128
Los Angeles, CA 90095Phone+1 310-825-5321Fax+1 310-825-0644
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2003 - 2006
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2000 - 2003
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1999 - 2000
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2026
NV State Medical License 2008 - 2009- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesNeuro-Oncology
Clinical Trials
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2010 Apr 28
- Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme Start of enrollment: 2012 Dec 07
- Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2014 Jul 02
- Join now to see all
Publications & Presentations
PubMed
- Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma.Sonoko Oshima, Jingwen Yao, Samuel Bobholz, Raksha Nagaraj, Catalina Raymond
CNS Oncology. 2024-12-31 - Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.Nicholas S Cho, Francesco Sanvito, Viên Lam Le, Sonoko Oshima, Ashley Teraishi
Neuroradiology. 2024-12-01 - Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma.Nicholas S Cho, Chencai Wang, Kathleen Van Dyk, Francesco Sanvito, Sonoko Oshima
AJNR. American Journal of Neuroradiology. 2024-10-03
Professional Memberships
- Member
- Society for Neuro-OncologyMember
Other Languages
- Vietnamese
External Links
- UCLA Healthhttps://www.uclahealth.org/phioanh-nghiemphu
- Neuro-Oncologyhttp://www.neurooncology.ucla.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
